100 GENES FOUNDi

Show / hide columns »

XML | RDF | TAB | Page of 2 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Vesicles
Tissue enhanced
CACNA1BCalcium channel, voltage-dependent, N type, alpha 1B subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Nuclear membraneMixed
CACNA1ECalcium channel, voltage-dependent, R type, alpha 1E subunitPredicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Actin filaments
Cytosol
Tissue enriched
CACNA1GCalcium channel, voltage-dependent, T type, alpha 1G subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium channel, voltage-dependent, T type, alpha 1H subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Vesicles
Tissue enhanced
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CATSPER4Cation channel, sperm associated 4Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
CNGA1Cyclic nucleotide gated channel alpha 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Vesicles
Plasma membrane
Mixed
CNGA2Cyclic nucleotide gated channel alpha 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
CNGB3Cyclic nucleotide gated channel beta 3Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
HCN1Hyperpolarization activated cyclic nucleotide gated potassium channel 1Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
HCN3Hyperpolarization activated cyclic nucleotide gated potassium channel 3Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCNA1Potassium channel, voltage gated shaker related subfamily A, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium channel, voltage gated shaker related subfamily A, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Cytosol
Tissue enhanced
KCNA2Potassium channel, voltage gated shaker related subfamily A, member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium channel, voltage gated shaker related subfamily A, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium channel, voltage gated shaker related subfamily A, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium channel, voltage gated shaker related subfamily A, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6 FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium channel, voltage gated Shab related subfamily B, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium channel, voltage gated Shab related subfamily B, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Plasma membrane
Midbody
Tissue enhanced
KCNC1Potassium channel, voltage gated Shaw related subfamily C, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleus
Nuclear membrane
Vesicles
Cytosol
Tissue enriched
KCNC2Potassium channel, voltage gated Shaw related subfamily C, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Cytosol
Tissue enriched
KCNC3Potassium channel, voltage gated Shaw related subfamily C, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC4Potassium channel, voltage gated Shaw related subfamily C, member 4Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Cytosol
Mixed
KCND1Potassium channel, voltage gated Shal related subfamily D, member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
NucleusMixed
KCND2Potassium channel, voltage gated Shal related subfamily D, member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium channel, voltage gated Shal related subfamily D, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNF1Potassium channel, voltage gated modifier subfamily F, member 1Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Golgi apparatusTissue enriched
KCNG1Potassium channel, voltage gated modifier subfamily G, member 1Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
VesiclesTissue enhanced
KCNG2Potassium channel, voltage gated modifier subfamily G, member 2Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNG3Potassium channel, voltage gated modifier subfamily G, member 3Predicted membrane proteins
Voltage-gated ion channels
Cytoplasmic bodiesTissue enhanced
KCNG4Potassium channel, voltage gated modifier subfamily G, member 4Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNH1Potassium channel, voltage gated eag related subfamily H, member 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesTissue enriched
KCNH3Potassium channel, voltage gated eag related subfamily H, member 3Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleus
Mitochondria
Group enriched
KCNH5Potassium channel, voltage gated eag related subfamily H, member 5Predicted membrane proteins
Voltage-gated ion channels
Microtubules
Mitotic spindle
Tissue enhanced
KCNH7Potassium channel, voltage gated eag related subfamily H, member 7Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNJ1Potassium channel, inwardly rectifying subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium channel, inwardly rectifying subfamily J, member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium channel, inwardly rectifying subfamily J, member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Cytosol
Group enriched
KCNJ14Potassium channel, inwardly rectifying subfamily J, member 14Predicted membrane proteins
Voltage-gated ion channels
NucleoliMixed
KCNJ15Potassium channel, inwardly rectifying subfamily J, member 15Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Vesicles
Plasma membrane
Cytosol
Tissue enhanced
KCNJ16Potassium channel, inwardly rectifying subfamily J, member 16Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
VesiclesGroup enriched
KCNJ2Potassium channel, inwardly rectifying subfamily J, member 2Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ3Potassium channel, inwardly rectifying subfamily J, member 3Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ5Potassium channel, inwardly rectifying subfamily J, member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ8Potassium channel, inwardly rectifying subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNJ9Potassium channel, inwardly rectifying subfamily J, member 9Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched

Page of 2 | next »